Xin-Jia Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin-Jia Cai has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Tie-Jun Li
Department of Oral Pathology Peking University School and Hospital of Stomatology Beijing China
29 shared publications - He-Yu Zhang
Research Unit of Precision Pathologic Diagnosis in Tumors of the Oral and Maxillofacial Regions, Chinese Academy of Medical Sciences (2019RU034), Beijing, China
24 shared publications - Chao-Ran Peng
National Center of Stomatology and National Clinical Research Center for Oral Diseases and National Engineering Research Center of Oral Biomaterials and Digital Medical Devices
23 shared publications - Jian-Yun Zhang
Department of Oral Pathology, Peking University School and Hospital of Stomatology; National Center for Stomatology; National Clinical Research Center for Oral Diseases; National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, 100081, China.
23 shared publications - Xu Wang
Department of Oral Medicine, Peking University School and Hospital of Stomatology
22 shared publications - Xin Peng
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology
21 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5)
Burden of Lip, Oral Cavity, and Pharyngeal Cancers in China: Estimated in 2022 and Projections to 2050
- 3 September 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5)
Open AccessBurden of Lip, Oral Cavity, and Pharyngeal Cancers in China: Estimated in 2022 and Projections to 2050
- Open Access
- 3 September 2026
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 07, 1001426
A computational pathology-based AI framework for predicting PD-L1 expression and prognosis in HNSCC
Aim: To investigate interobserver variability in programmed cell death ligand 1 (PD-L1) combined positive score (CPS) assessment in head and neck squamous cell carcinoma (HNSCC) and to develop an artificial intelligence (AI)-based model for predicting PD-L1 expression and patient prognosis from hematoxylin and eosin (H&E)-stained slides. Methods: Fifty HNSCC specimens were independently evaluated for PD-L1 by pathologists with different experience levels. Agreement was assessed using Fleiss’ and Cohen’s κ. Whole-slide images were processed into tiles for deep learning using DenseNet121. Tile-level features were integrated via two machine learning pipelines to construct whole-slide prediction models. Multiple algorithms were tested, with performance evaluated in validation and testing cohorts. Prognostic value was analyzed using AI-derived risk stratification. Results: Interobserver agreement was low (Fleiss’ κ = 0.34), indicating substantial variability in CPS assessment. DenseNet121 achieved moderate predictive performance (AUC 0.641 in validation, 0.616 in testing). AI models significantly improved prediction accuracy, with logistic regression demonstrating the best performance (AUC 0.900 in validation, 0.851 in testing). AI-derived prediction scores effectively stratified overall survival, with multiple models showing significant prognostic discrimination (P < 0.05). Conclusions: AI models integrating deep learning and machine learning can accurately predict PD-L1 expression and stratify prognosis in HNSCC, outperforming tile-level deep learning alone.
- 3 September 2026
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 07, 1001426
Open AccessA computational pathology-based AI framework for predicting PD-L1 expression and prognosis in HNSCC
Aim: To investigate interobserver variability in programmed cell death ligand 1 (PD-L1) combined positive score (CPS) assessment in head and neck squamous cell carcinoma (HNSCC) and to develop an artificial intelligence (AI)-based model for predicting PD-L1 expression and patient prognosis from hematoxylin and eosin (H&E)-stained slides. Methods: Fifty HNSCC specimens were independently evaluated for PD-L1 by pathologists with different experience levels. Agreement was assessed using Fleiss’ and Cohen’s κ. Whole-slide images were processed into tiles for deep learning using DenseNet121. Tile-level features were integrated via two machine learning pipelines to construct whole-slide prediction models. Multiple algorithms were tested, with performance evaluated in validation and testing cohorts. Prognostic value was analyzed using AI-derived risk stratification. Results: Interobserver agreement was low (Fleiss’ κ = 0.34), indicating substantial variability in CPS assessment. DenseNet121 achieved moderate predictive performance (AUC 0.641 in validation, 0.616 in testing). AI models significantly improved prediction accuracy, with logistic regression demonstrating the best performance (AUC 0.900 in validation, 0.851 in testing). AI-derived prediction scores effectively stratified overall survival, with multiple models showing significant prognostic discrimination (P < 0.05). Conclusions: AI models integrating deep learning and machine learning can accurately predict PD-L1 expression and stratify prognosis in HNSCC, outperforming tile-level deep learning alone.
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Spatially resolved proteomics provides insights into the normal-dysplasia-tumor continuum in oral squamous cell carcinoma
Oral epithelial dysplasia is a recognized precursor lesion for oral squamous cell carcinoma (OSCC), yet the proteomic changes underlying the progression fr
- 16 July 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessSpatially resolved proteomics provides insights into the normal-dysplasia-tumor continuum in oral squamous cell carcinoma
Oral epithelial dysplasia is a recognized precursor lesion for oral squamous cell carcinoma (OSCC), yet the proteomic changes underlying the progression fr
- Open Access
- 29 June 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Dissecting oral premalignant carcinogenesis: spatial omics mechanisms and nanomedicine-driven therapeutic innovation
Oral potentially malignant disorder (OPMD) remains a critical clinical challenge for cancer interception. However, the progression of OPMD toward oral squamous cell carcinoma (OSCC) is driven by profound cellular heterogeneity and dynamic microenvironmental remodeling. The mechanisms underlying these processes are not yet fully understood. Recent advancements in single-cell and spatial omics have facilitated high-resolution decoding of the precancerous landscape, unveiling multistep epithelial cell plasticity, fibroblast heterogeneity with extracellular matrix remodeling, immune suppression, and inflammatory reprogramming, as well as coupled metabolic and redox alterations that govern malignant transformation. These insights into the cellular mechanisms have led to a paradigm shift in the understanding of OPMD, reclassifying it as an ecosystem-level disease rather than a purely epithelial pathology. Nanomedicine is a potent platform for translating mechanistic knowledge into precision diagnostics and interventions at the precancerous stage. Nanomaterial-based strategies have been demonstrated to facilitate several critical processes, including enabling early lesion visualization and risk stratification, immune microenvironment reactivation, anti-fibrotic and anti-inflammatory remodeling, and targeted regulation of metabolic and oxidative stress pathways. A mounting body of evidence from preclinical and clinical studies lends support to the notion that nanotechnology-assisted early detection, microenvironmental reprogramming, and the interception of malignant transformation across oral and other precancerous conditions are indeed feasible. This review integrates single-cell-resolved mechanisms of OPMD progression with state-of-the-art nanomedicine-based diagnostic and therapeutic strategies, highlighting convergent biological axes and translational opportunities. By integrating single-cell biology with nanotechnology-driven precision medicine, this work is expected to improve the development of a nanomedicine framework for early cancer detection and treatment and outline future directions and challenges toward clinical implementation.
- 29 June 2026
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Open AccessDissecting oral premalignant carcinogenesis: spatial omics mechanisms and nanomedicine-driven therapeutic innovation
Oral potentially malignant disorder (OPMD) remains a critical clinical challenge for cancer interception. However, the progression of OPMD toward oral squamous cell carcinoma (OSCC) is driven by profound cellular heterogeneity and dynamic microenvironmental remodeling. The mechanisms underlying these processes are not yet fully understood. Recent advancements in single-cell and spatial omics have facilitated high-resolution decoding of the precancerous landscape, unveiling multistep epithelial cell plasticity, fibroblast heterogeneity with extracellular matrix remodeling, immune suppression, and inflammatory reprogramming, as well as coupled metabolic and redox alterations that govern malignant transformation. These insights into the cellular mechanisms have led to a paradigm shift in the understanding of OPMD, reclassifying it as an ecosystem-level disease rather than a purely epithelial pathology. Nanomedicine is a potent platform for translating mechanistic knowledge into precision diagnostics and interventions at the precancerous stage. Nanomaterial-based strategies have been demonstrated to facilitate several critical processes, including enabling early lesion visualization and risk stratification, immune microenvironment reactivation, anti-fibrotic and anti-inflammatory remodeling, and targeted regulation of metabolic and oxidative stress pathways. A mounting body of evidence from preclinical and clinical studies lends support to the notion that nanotechnology-assisted early detection, microenvironmental reprogramming, and the interception of malignant transformation across oral and other precancerous conditions are indeed feasible. This review integrates single-cell-resolved mechanisms of OPMD progression with state-of-the-art nanomedicine-based diagnostic and therapeutic strategies, highlighting convergent biological axes and translational opportunities. By integrating single-cell biology with nanotechnology-driven precision medicine, this work is expected to improve the development of a nanomedicine framework for early cancer detection and treatment and outline future directions and challenges toward clinical implementation.
- Open Access
- 16 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (4) , 109674
Meta-Analysis and Systematic Review of Immune Checkpoint Expression in Predicting the Risk of Malignant Transformation in Oral Potentially Malignant Disorders
- 16 June 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (4) , 109674
Open AccessMeta-Analysis and Systematic Review of Immune Checkpoint Expression in Predicting the Risk of Malignant Transformation in Oral Potentially Malignant Disorders
- Open Access
Neurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges
Neurovascular interaction plays a central role in bone development, repair and regeneration. The coordinated activity between nerves and blood vessels not only ensures the delivery of oxygen, nutrients, and regulatory signals but also modulates skeletal cell behavior and immune responses. However, traditional therapeutic strategies, such as autografts and allografts, and synthetic scaffolds often fail to replicate the native neurovascular microenvironment, limiting their regenerative efficacy. This review outlines the regulatory mechanisms of neurovascular coupling in bone regeneration. Neural inputs, mediated through neurotrophic factors and neurotransmitters, regulate bone homeostasis by influencing the activity of osteoblasts and osteoclasts, while vascular networks supply essential oxygen and nutrients to support bone maintenance and repair. We then summarize recent advances in neurovascularized biomaterials, including neurotrophic factor‐loaded scaffolds, electroconductive composites, ion‐releasing ceramics, and endogenous electroactive materials, which enable synchronous neural, vascular, and osteogenic regeneration. In addition to functional materials, cell‐ and molecule‐based approaches further enhance neurovascularized bone repair. Together, these strategies represent a shift from passive fillers to multifunctional scaffolds capable of fulfilling complex repair processes. This review aims to bridge mechanistic understanding with material design, offering insights for next‐generation bone tissue engineering.
Open AccessNeurovascular coupling in bone regeneration: Mechanisms, advanced biomaterials and challenges
Neurovascular interaction plays a central role in bone development, repair and regeneration. The coordinated activity between nerves and blood vessels not only ensures the delivery of oxygen, nutrients, and regulatory signals but also modulates skeletal cell behavior and immune responses. However, traditional therapeutic strategies, such as autografts and allografts, and synthetic scaffolds often fail to replicate the native neurovascular microenvironment, limiting their regenerative efficacy. This review outlines the regulatory mechanisms of neurovascular coupling in bone regeneration. Neural inputs, mediated through neurotrophic factors and neurotransmitters, regulate bone homeostasis by influencing the activity of osteoblasts and osteoclasts, while vascular networks supply essential oxygen and nutrients to support bone maintenance and repair. We then summarize recent advances in neurovascularized biomaterials, including neurotrophic factor‐loaded scaffolds, electroconductive composites, ion‐releasing ceramics, and endogenous electroactive materials, which enable synchronous neural, vascular, and osteogenic regeneration. In addition to functional materials, cell‐ and molecule‐based approaches further enhance neurovascularized bone repair. Together, these strategies represent a shift from passive fillers to multifunctional scaffolds capable of fulfilling complex repair processes. This review aims to bridge mechanistic understanding with material design, offering insights for next‐generation bone tissue engineering.
- Open Access
- 22 April 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Computational pathology-based artificial intelligence platform for the identification of common oral potentially malignant disorders
Oral potentially malignant disorders (OPMDs) refer to a group of significant precursor lesions for oral squamous cell carcinoma (OSCC). Early differential
- 22 April 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessComputational pathology-based artificial intelligence platform for the identification of common oral potentially malignant disorders
Oral potentially malignant disorders (OPMDs) refer to a group of significant precursor lesions for oral squamous cell carcinoma (OSCC). Early differential
- 30 January 2026
- Published by Elsevier in Oral Oncology
- Vol. 174, 107875
Integrating betel nut control into routine health management strategies
- 30 January 2026
- Published by Elsevier in Oral Oncology
- Vol. 174, 107875
Integrating betel nut control into routine health management strategies
- Open Access
- 19 December 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 109342
Scientific Mapping and Knowledge Evolution of Global Areca Research
- 19 December 2025
- Published by Elsevier in International Dental Journal
- Vol. 76 (1) , 109342
Open AccessScientific Mapping and Knowledge Evolution of Global Areca Research
- 1 June 2025
- Vol. 43 (3) , 314-324
[Progress in clinicopathological diagnosis of oral potentially malignant disorders].
As the field of oral pathology has evolved, the nomenclature and classification of oral mucosal diseases with a remarkable risk of malignant transformation have undergone several modifications. In 2005, the World Health Organization (WHO) introduced the concept of oral potentially malignant disorders (OPMDs) as an alternative to the terms for oral precancerous lesions and precancerous conditions. In the consensus report by the WHO Collaborating Center for Oral Cancer of 2021, OPMD is defined as "any oral mucosal abnormality that is associated with a statistically increased risk of developing oral cancer."This definition encompasses a range of conditions, in-cluding oral leukoplakia, oral submucous fibrosis, proliferative verrucous leukoplakia, oral lichen planus, and other lesions. In light of the complex etiology, unclear pathogenesis, and carcinogenesis of OPMDs, early and precise diagnosis and treatment can contribute to the secondary prevention of oral cancer. For this reason, this review, which aims to provide a basis for the precise clinical diagnosis of OPMDs, was performed. Its aim was achieved by reviewing the historical evolution and research progress of the nomenclature, classification, and histopathological diagnostic criteria of OPMDs.
- 1 June 2025
- Vol. 43 (3) , 314-324
[Progress in clinicopathological diagnosis of oral potentially malignant disorders].
As the field of oral pathology has evolved, the nomenclature and classification of oral mucosal diseases with a remarkable risk of malignant transformation have undergone several modifications. In 2005, the World Health Organization (WHO) introduced the concept of oral potentially malignant disorders (OPMDs) as an alternative to the terms for oral precancerous lesions and precancerous conditions. In the consensus report by the WHO Collaborating Center for Oral Cancer of 2021, OPMD is defined as "any oral mucosal abnormality that is associated with a statistically increased risk of developing oral cancer."This definition encompasses a range of conditions, in-cluding oral leukoplakia, oral submucous fibrosis, proliferative verrucous leukoplakia, oral lichen planus, and other lesions. In light of the complex etiology, unclear pathogenesis, and carcinogenesis of OPMDs, early and precise diagnosis and treatment can contribute to the secondary prevention of oral cancer. For this reason, this review, which aims to provide a basis for the precise clinical diagnosis of OPMDs, was performed. Its aim was achieved by reviewing the historical evolution and research progress of the nomenclature, classification, and histopathological diagnostic criteria of OPMDs.